Press Release – Awardees Announced for the DR-TB Lifeline QuickFire Challenge

Share

Johnson & Johnson logo. Public domainMedia contacts

Joshina Kapoor (India) jkapoor2@ITS.JNJ.com  +919820711080  

Jessica Freifeld (Global) jfreifel@its.jnj.com  +1 917-520-1198  

Awardees Announced for the DR-TB Lifeline QuickFire Challenge

  • Two of the five awardees – who will receive both $50,000 in grant funding and mentorship from  J&J experts – are Indian NGOs renowned for their work in TB Care and Management – Doctors  For You and ZMQ Global.  
  • In leveraging telemedicine and patient-centric mobile solutions, the winners aim to ensure  continued access to critical DR-TB care and management to the patients. 

September 16, 2020 Johnson & Johnson’s Global Public Health team, together with Johnson & Johnson  Innovation – JLABS, announced today that DOCTORS FOR YOU, ZMQ Global, De La Salle Medical and  Health Sciences Institute, Keheala and CO TBpeopleUkraine, have been selected as the awardees in the  Drug Resistant-TB Lifeline QuickFire Challenge. The Challenge was designed with the aim to ensure  continuity of care for those diagnosed with and undergoing treatment for DR-TB in the wake of the COVID 19 pandemic. 

To advance their research, the awardees will receive a combined total of $250,000 in grant funding and  will also have the opportunity to engage with experts at the Johnson & Johnson Family of Companies. 

DOCTORS FOR YOU 

An implementable & sustainable solution to continue provide critical DR-TB care services during ongoing  COVID-19 using Telemedicine & NIKSHAY DR-TB services delivery boy to strengthen National Tuberculosis  Elimination Program (NTEP) of Govt. of India. 

ZMQ Global 

PACT – Patient’s Active Compliance and Treatment toolkit is a patient-centric mobile solution which has 3  main features – Adherence reporting using VOT (asynchronous video observed treatment reporting) &  self-tracking of treatment; Health System Connect for Consultation & Emergency Care (synchronous video  observation therapy mode); and built-in digital tools for Behavior Change Communication to motivate DR TB patients and build their capacities. 

De La Salle Medical and Health Sciences Institute 

Asynchronized VOT utilizing SureAdhere software, a simple application that can be downloaded to any  smartphone that records patients dosing for healthcare workers to view for compliance.

Keheala 

Keheala is a digital adherence technology, which uses behavioral economics and basic feature phones to  ‘nudge’ and support patients through their treatment process.  

CO TBpeopleUkraine 

By scaling-up OneImpact mobile application as an efficient tool to enhance TB-patient outreach, monitor  barriers and rights violations, TBpeopleUkraine empowers the TB community to respond to challenges  encountered during TB-treatment in a timely manner in order to support adherence, reduce the risks of  separation from therapy and implement patient-centered approach in treatment and care model.  

The QuickFire Challenges are managed by Johnson & Johnson Innovation, JLABS, with the aim to address  today’s greatest health care challenges.  

About Johnson & Johnson’s Global Public Health  

Charting a bold new, self-sustainable approach, Johnson & Johnson has established the first fully dedicated organization within a healthcare company focused on combining innovative R&D, novel access  programs & approaches, in-country operations, advocacy and the power of multi-sectoral partnerships to  ensure that treatments and technologies are available, affordable and accessible for the world’s most  under-served populations. Harnessing the extensive resources and expertise from across Johnson &  Johnson, its Global Public Health team is placing an unparalleled focus on accelerating the pace of  innovation needed – from discovery to delivery – to make TB and HIV history, eliminate intestinal worms,  address mental health and wrestle other public health challenges.

Learn more at www.jnj.com/global-public-health and follow us @JNJGlobalHealth

About Johnson & Johnson Innovation 

Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming  collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. Johnson &  Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to  science and technology experts who can facilitate collaborations across the pharmaceutical, medical  device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation  umbrella of businesses, we connect with innovators through our regional Innovation Centers; Johnson &  Johnson Innovation – JLABS; Johnson & Johnson Innovation – JJDC, Inc.; and our business development  teams to create customized deals and novel collaborations that speed development of innovations to  solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools and resources  needed to help life science startups thrive, all with no strings attached. A Johnson & Johnson Innovation  Center for Device Innovation at the Texas Medical Center (CDI @ TMC) has been established to accelerate  the development of medical devices. For more information about Johnson & Johnson Innovation, please visit: www.jnjinnovation.com.

About Johnson & Johnson Innovation – JLABS 

Johnson & Johnson Innovation JLABS (JLABS) is a global network of open innovation ecosystems,  enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical,  medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing  the optimal environment for emerging companies to catalyze growth and optimize their research and  development by opening them to vital industry connections, delivering entrepreneurial programs and  providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today  into the breakthrough healthcare solutions of tomorrow. At JLABS, we value great ideas and are  passionate about removing obstacles to success to help innovators unleash the potential of their early  scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to  develop their science while holding on to their intellectual property. JLABS also produces campaigns to  seek out the best science called QuickFire Challenges. For more information, visit www.jnj.com/global-public-health and follow us @JNJGlobalHealth. 

Read more from the Health Issues India press office here.



https://www.healthissuesindia.com/2020/09/17/press-release-awardees-announced-for-the-dr-tb-lifeline-quickfire-challenge/

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: